Abstract |
A major impediment to effective anti-leishmanial chemotherapy is the emergence of drug resistance, especially to sodium antimony gluconate, the first-line treatment for leishmaniasis. Artemisinin, a sesquiterpene lactone isolated from Artemisia annua, is an established anti-malarial compound that showed anti-leishmanial activity in both promastigotes and amastigotes, with IC(50) values of 160 and 22 microM, respectively, and, importantly, was accompanied by a high safety index (>22-fold). The leishmanicidal activity of artemisinin was mediated via apoptosis as evidenced by externalization of phosphatidylserine, loss of mitochondrial membrane potential, in situ labelling of DNA fragments by terminal deoxyribonucleotidyltransferase-mediated dUTP nick end labelling (TUNEL) and cell-cycle arrest at the sub-G(0)/G(1) phase. Taken together, these data indicate that artemisinin has promising anti-leishmanial activity that is mediated by programmed cell death and, accordingly, merits consideration and further investigation as a therapeutic option for the treatment of leishmaniasis.
|
Authors | Rupashree Sen, Samiran Bandyopadhyay, Avijit Dutta, Goutam Mandal, Sudipto Ganguly, Piu Saha, Mitali Chatterjee |
Journal | Journal of medical microbiology
(J Med Microbiol)
Vol. 56
Issue Pt 9
Pg. 1213-1218
(Sep 2007)
ISSN: 0022-2615 [Print] England |
PMID | 17761485
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antiprotozoal Agents
- Artemisinins
- Phosphatidylserines
- artemisinin
|
Topics |
- Animals
- Antiprotozoal Agents
(pharmacology)
- Apoptosis
- Artemisinins
(pharmacology)
- Cell Cycle
(drug effects)
- Cell Membrane
(chemistry)
- DNA Breaks, Single-Stranded
- Humans
- In Situ Nick-End Labeling
- Inhibitory Concentration 50
- Leishmania donovani
(cytology, drug effects)
- Membrane Potential, Mitochondrial
(drug effects)
- Phosphatidylserines
(analysis)
|